ACRS: Aclaris Therapeutics Inc

1.55 USD 0.06 (3.73%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

ACRS exchange rate has changed by -3.73% for today. During the day, the instrument was traded at a low of 1.50 and at a high of 1.86.

Follow Aclaris Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

ACRS News

Zacks 14:00 Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
Investing 21:28 Aclaris Therapeutics stock soars after positive Phase 2a trial results
Investing 20:09 Aclaris reports positive results from ATI-2138 atopic dermatitis trial
Investing 17:01 Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans
Investing 13:37 Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes
Investing 20:48 Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
Investing 11:29 Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody
Investing 11:20 Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
Investing 11:04 InvestingPro’s Fair Value model captures 67% upside in Aclaris Therapeutics
Investing 11:32 H.C. Wainwright maintains Buy on Aclaris stock, $16 target
Investing 18:02 Aclaris Therapeutics at Jefferies Conference: Strategic Pipeline Advances
Investing 11:05 Aclaris begins phase 2 trial for atopic dermatitis drug
Investing 13:32 Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Investing 12:22 Wedbush sets Aclaris stock Outperform with $8 target
Benzinga 11:43 This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Aclaris Therapeutics (NASDAQ:ACRS), Alkermes (NASDAQ:ALKS)
Investing 19:09 Insurance broker Acrisure valued at $32 billion in funding round led by Bain Capital
Investing 12:44 H.C. Wainwright cuts Aclaris stock price target to $16
Seeking Alpha 12:09 Aclaris: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule

Daily Range

1.50 1.86

Year Range

1.05 5.17

Previous Close: 1.55
Open: 1.61

Bid: 1.55
Ask: 1.85

Low: 1.50
High: 1.86

Volume: 4.911 K

Daily Change: -3.73%
Month Change: 7.64%

6 Months Change: -35.95%
Year Change: 12.32%

30 July, Wednesday